| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 06/17/2009 | EP1436384B1 Mutated abl kinase domains |
| 06/17/2009 | EP1390408A4 A molecular marker |
| 06/17/2009 | EP1179003B1 Methods for increasing plant cell proliferation by functionally inhibiting a plant cyclin inhibitor gene |
| 06/17/2009 | EP1147211B1 High level expression of a heterologous protein having rare codons |
| 06/17/2009 | CN101456887A Use of siRNA in preparing medicament for regulating and controlling tumour cell division cycle |
| 06/17/2009 | CN100500849C Expressing Ompk antigen of outer-membrane protein of Vibrio Harveyi and application as constituent of bacteria |
| 06/16/2009 | US7547821 Methods for the production of insulin in plants |
| 06/16/2009 | US7547775 Synthesis and purification of oligonucleotide having free 3'-hydroxyl groups from a high density oligonucleotide array; transesterification ; |
| 06/16/2009 | US7547774 RCc3 regulatory elements for use in plants |
| 06/16/2009 | US7547773 Binding site amino acid sequences for use as targeting agents in immunotherapeutics; antitumor agents; which conforms to human leukocyte antigen (HLA) motifs; immunogens; cytotoxic T lymphocytes; comprises proteases; prostate cancer |
| 06/16/2009 | US7547772 Chimeric nucleic acid constructs and compositions comprising sets of nucleic acid constructs |
| 06/16/2009 | US7547771 Biallelic tumor markers for use as diagnostic/prognostic indicators of cell proliferative disorders |
| 06/16/2009 | US7547768 Anti-TAT 113 antibodies |
| 06/16/2009 | US7547682 Useful as a candidate for a vaccine against ticks, particularly Ornithodoros moubata, tick-borne infections such as rickettsiosis, filariasis, Q fever, African recurrent fever, or viral encephalitis |
| 06/16/2009 | US7547535 Mutant form of soluble pyrroloquinoline quinone-dependent glucose dehydrogenase (PQQ) monitoring glucose level in blood, serum and urine |
| 06/16/2009 | US7547531 L-amino acid producing microorganism which has been modified to inactive the fimH gene, and a method for producing I-amino acid |
| 06/16/2009 | US7547530 Nucleotide compositions comprising photocleavable markers and methods of preparation thereof |
| 06/16/2009 | US7547513 Mutants of deoxycytidine kinase having extended enzymatic activity |
| 06/16/2009 | US7547511 Antisense inhibition of laminin-8 expression to inhibit human gliomas |
| 06/16/2009 | US7547510 Isolating heat resistant cellulase from bacillus culture using temperature variance and fraction separation |
| 06/16/2009 | CA2497493C Adsorption of nucleic acids to a solid phase |
| 06/11/2009 | WO2009073821A2 Biopolymer-nucleic acid conjugation |
| 06/11/2009 | WO2009073820A2 Biopolymer-nucleic acid conjugation |
| 06/11/2009 | WO2009070957A1 Inhibitor of the interaction between blys and ngr and use thereof |
| 06/11/2009 | WO2009070883A1 Polymer synthesizer |
| 06/11/2009 | WO2009070843A1 Bisulphite treatment of rna |
| 06/11/2009 | WO2009033120A3 Use of iridoptin to induce toxicity in insects |
| 06/11/2009 | WO2007038155A3 Methods of diagnosing cardiovascular disease |
| 06/11/2009 | WO2007021896A3 Chemically modified oligonucleotides for use in modulating micro rna and uses thereof |
| 06/11/2009 | WO2006138689A3 Improved amino acid and metabolite biosynthesis |
| 06/11/2009 | WO2006137939A3 Compositions and methods for detecting group a streptococci |
| 06/11/2009 | WO2006029256A3 Compositions, methods, and systems for determining bovine parentage and identity |
| 06/11/2009 | WO2006010150A3 Housekeeping genes and methods for identifying the same |
| 06/11/2009 | WO2005082041A3 Enhanced detection of rna using a panel of truncated gene-specific primers for reverse transcription |
| 06/11/2009 | WO2003021227A3 Methods and compositions useful for diagnosis, staging, and treatment of cancers and tumors |
| 06/11/2009 | WO2002099058A3 KCNMAs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| 06/11/2009 | WO2002048314A3 Antisense modulation of raidd expression |
| 06/11/2009 | WO2002040632A3 Creation and identification of proteins having new dna binding specificities |
| 06/11/2009 | WO2002026930A3 Nucleic acids, proteins, and antibodies |
| 06/11/2009 | WO2001061028A3 Methods and products for peptide based dna sequence identification and analysis |
| 06/11/2009 | US20090151026 Polypeptides having feruloyl esterase activity and polynucleotides encoding same |
| 06/11/2009 | US20090151025 Indeterminate Gametophyte 1 (ig1), Mutations of ig1, Orthologs of ig1, and Uses Thereof |
| 06/11/2009 | US20090151020 Chimeric and proline rich protein promoters for expression in plants |
| 06/11/2009 | US20090151017 altering cellulose synthase concentration in the cell wall and thereby altering plant stalk quality for improved standability or silage |
| 06/11/2009 | US20090151015 Disease-inducible promoters |
| 06/11/2009 | US20090151013 Modified ES cells and ES cell-specific genes |
| 06/11/2009 | US20090150080 Methods of genetic analysis involving the amplification of complementary duplicons |
| 06/11/2009 | US20090149646 Isolation of Nucleic Acid |
| 06/11/2009 | US20090149644 siRNA Targeting KRAS |
| 06/11/2009 | US20090149643 polyoxyethylene glycol modified modified aptamer with phosphorothioate backbone modification, an inverted deoxythymidine, 5'-hexylamine linker phosphoramidite, 2'-O Methyl containing residue; modulates von Willebrand Factor-mediated platelet adhesion, activation and/or aggregation |
| 06/11/2009 | US20090149642 Enriched preparation of human fetal multipotential neural stem cells |
| 06/11/2009 | US20090149641 Fish disease protection |
| 06/11/2009 | US20090149640 Nucleic acid ladders |
| 06/11/2009 | US20090149428 Methods for Assessing the Predisposition or Susceptibility to COPD |
| 06/11/2009 | US20090149411 Immunostimulatory oligonucleotides with modified bases and methods of use thereof |
| 06/11/2009 | US20090149408 nucleotide sequence complementary to a target RNA sequence and a second sequence chemically modified so it can no longer act as a guide sequence for mediating RNA interference, having complementarity to said first sequence; inflammatory, respiratory, proliferative, autoimmune, cardiovascular diseases |
| 06/11/2009 | US20090149407 RNA INTERFERENCE MEDIATED TREATMENT OF ALZHEIMER'S DISEASE USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 06/11/2009 | US20090149404 Oligonucleotide analogues and methods utilizing the same |
| 06/11/2009 | US20090149403 siRNA silencing of genes expressed in cancer |
| 06/11/2009 | US20090149372 bone morphogenic proteins; transforming growth factors; fusion proteins; drug screening; cardiovascular disorders |
| 06/11/2009 | US20090149337 Use of an Extraction Control in a Method of Extracting Nucleic Acids |
| 06/11/2009 | US20090148958 Nucleotide-transition metal complex catalyst |
| 06/11/2009 | US20090148948 Nucleic acids encoding a g-protein coupled receptor involved in taste transduction |
| 06/11/2009 | US20090148944 CELL-TYPE SPECIFIC APTAMER-siRNA DELIVERY SYSTEM FOR HIV-1 THERAPY |
| 06/11/2009 | US20090148940 Novel fluorescent proteins from aequorea coerulscens and methods for using same |
| 06/11/2009 | US20090148916 PROCESS FOR PRODUCING HMG-CoA REDUCTASE INHIBITOR |
| 06/11/2009 | US20090148909 Gene sms 27 |
| 06/11/2009 | US20090148906 Optimized messenger rna |
| 06/11/2009 | US20090148905 Antigen-binding constructs |
| 06/11/2009 | US20090148903 Polypeptides having beta-glucosidase activity and polynucleotides encoding same |
| 06/11/2009 | US20090148902 Polypeptides having endoglucanase activity and polynucleotides encoding same |
| 06/11/2009 | US20090148901 Polypeptides having xylanase activity and polynucleotides encoding same |
| 06/11/2009 | US20090148900 Hemcm42 nucleic acids |
| 06/11/2009 | US20090148897 Human Ron-Related Gene Variant Associated With Cancers |
| 06/11/2009 | US20090148893 Novel Subtilases |
| 06/11/2009 | US20090148890 Nucleic acid and amino acid sequences relating to streptococcus pneumoniae for diagnostics and therapeutics |
| 06/11/2009 | US20090148855 Nucleic acid encoding or targeting sodium channel scn3a alpha subunits |
| 06/11/2009 | US20090148847 Rapid magnetic flow assays |
| 06/11/2009 | US20090148844 Dna marker for meat tenderness in cattle |
| 06/11/2009 | US20090148834 Methods of use of alpha-methylacyl-CoA racemase in hormone refractory and metastatic prostate cancers |
| 06/11/2009 | US20090148829 Methods For Rapid Identification Of Pathogens In Humans And Animals |
| 06/11/2009 | US20090148471 Molecular Vaccine Linking an Endoplasmic Reticulum Chaperone Polypeptide to an Antigen |
| 06/11/2009 | US20090148468 Screening blood and identifying immunologically active antigen of herpes simplex virus (HSV) which attacks skin; diagnosing viral infection; viricides |
| 06/11/2009 | US20090148466 Process for the Preparation of Hypoallergenic Mosaic Antigens |
| 06/11/2009 | US20090148465 Mutants of the p4 protein of nontypable haemophilus influenzae with reduced enzymatic activity |
| 06/11/2009 | US20090148461 Anti fgf23 antibody and a pharmaceutical composition comprising the same |
| 06/11/2009 | US20090148458 Coagulation factor iii polymorphisms associated with prediction of subject outcome and response to therapy |
| 06/11/2009 | US20090148455 Anti-RANTES antibodies and methods of use thereof |
| 06/11/2009 | US20090148451 Therapeutic anti-cytomegalovirus compounds |
| 06/11/2009 | US20090148450 ATF4 As A Therapeutic Target In Alzheimers Disease And Other Neurological Disorders |
| 06/11/2009 | US20090148441 Anti-Cancer Antibodies With Reduced Complement Fixation |
| 06/11/2009 | US20090148438 Binding Moieties Based on Shark Ignar Domains |
| 06/11/2009 | US20090148436 Antibody to gdf8 and uses thereof |
| 06/11/2009 | EP1613724A2 Cell lines and host nucleic acid sequences related to infectious disease |
| 06/11/2009 | CA2746074A1 Polymer synthesizer |
| 06/11/2009 | CA2707165A1 Bisulphite treatment of rna |
| 06/10/2009 | EP2067862A1 Gridlock nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 06/10/2009 | EP2067790A2 Agonist antibody against protein tyrosine kinase SAL-S1 |
| 06/10/2009 | EP2067783A1 Genetically engineered P30 antigen, improved antigen cocktail, and uses thereof |
| 06/10/2009 | EP2066817A1 Molecular switches and methods for their use |